Company: Quibim
Founder: Ángel Alberich-Bayarri
Website: https://quibim.com/
About Quibim
Quibim is a company leading at the forefront of imaging biomarkers research in life sciences, pioneering the development of advanced algorithms that transform imaging data into actionable predictions in oncology, immunology, and neurology.
The company, founded in 2012 with the commercial operations started in 2020, with the ambition to leverage imaging as a catalyst for precision medicine, improving clinical outcomes for patients and redefining medical treatment and monitoring.
We employ 100 people and maintain our headquarters in Valencia, where we have attracted AI specialists from more than 10 different nationalities. Additionally, the company has expanded globally and established offices in Cambridge (UK), New York (USA), Madrid and Barcelona (Spain).
We utilize MRI, CT, and PET imaging technologies to develop regulatory-cleared medical devices, integrating seamlessly into global healthcare workflows. The products developed by the company focus on the screening and detection of diseases, including cancer and neurodegenerative disorders, as well as on the personalization of treatment approaches. Our products adhere
to all relevant medical device regulations and data protection laws, securing necessary endorsements from regulatory authorities for international clinical use. Currently, our innovations are usedin more than 170 sites worldwide.
Our main products are:
QP-Prostate: QP-Prostate is an AI-powered diagnostic tool meticulously designed to enhance the efficiency of radiological diagnosis, empowering clinicians to deliver quicker and more accurate assessments, ultimately enhancing patient care.
This innovative solution offers:
• Automatic image quality evaluation
• Precise segmentation of the prostate gland
• Identification of suspicious lesions
QP-Brain: QP-Brain is an AI-based solution designed to improve the detection and understanding of brain atrophy and lesions. It automates the quantitative analysis
of brain MRI scans, optimizing both the diagnosis and subsequent monitoring of patients. This tool generates more comprehensive and detailed radiological reports, thereby increasing their efficacy.
QP-Liver: QP-Liver is an AI-driven product designed to optimize the diagnosis of diffuse liver diseases. It achieves this through the high-precision quantification of tissue fat and iron using images obtained from magnetic resonance imaging.
QP-Insights: QP-Insights emerges as the next-generation, comprehensive web-based cloud platform designed to provide a solution for managing, storing, and quantitatively analyzing large-scale multi-omics data with an image-centric approach, seamlessly interoperable with other registries. With a strong track record in the life sciences industry, demonstrated by its successful deployment at more than 150 global sites and by over 1000 clinicians and researchers, QP-Insights is redefining excellence in the management, storage, and quantitative analysis of medical images and other clinical and multi-omic information in clinical studies and research projects.
QP-Insights is the backbone platform for 9 large cancer registries and has already earned the trust of major biopharmaceutical companies for their data management needs. These collaborative efforts promote our mission of advancing precision medicine and patient health.
Check out what TechRound can do for your business: SEO, PR, HR Software, Payroll Software, IT, VoIP.
